| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 35.00× | 35.00× | 33.48× | 21.77× | 26.56× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.21× | 0.15× | 0.27× | 0.31× | 0.38× | ||
| 0.09× | 0.09× | 0.09× | 0.12× | 0.14× | ||
| −2.88× | −2.88× | −0.25× | 0.15× | 1.30× | ||
| 4.63× | 4.63× | 0.25× | −0.33× | 8.05× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 26.56 | 21.77 | 33.48 | 35.00 | 35.00 | |
| Working Capital Turnover | 0.38 | 0.31 | 0.27 | 0.15 | 0.21 | |
| Asset Turnover | 0.14 | 0.12 | 0.09 | 0.09 | 0.09 | |
| Cash Conversion (CFO/Net Income) | 1.30 | 0.15 | -0.25 | -2.88 | -2.88 | |
| CFO/EBITDA | 8.05 | -0.33 | 0.25 | 4.63 | 4.63 |